GlassScriptPhysician profile
Taylor Soon-Sutton
NPI 1649766130
$3,478.93
in general payments reported to CMS, 2019-2025
27 companies · $389 in 2025
The $389 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $187 · 2020: $14.21 · 2021: $688 · 2022: $579 · 2023: $744 · 2024: $877 · 2025: $389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,010.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,010.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $868.88 | 2021-2025 | Lithovue, Advance Xp, Tria Firm |
| Teleflex LLC | $386.84 | 2023-2025 | Urolift |
| Coloplast Corp | $316.25 | 2021-2023 | Titan |
| Intuitive Surgical, INC. | $275.40 | 2021 | |
| Astellas Pharma US INC | $202.06 | 2019-2022 | |
| Laborie Medical Technologies Corp. | $148.50 | 2023 | |
| Calyxo, INC. | $145.71 | 2025 | Cvac Aspiration System |
| Cook Medical LLC | $140.21 | 2024-2025 | Resonance, S~Curve |
| Abbvie INC. | $123.78 | 2024-2025 | |
| Karl Storz Endoscopy-America | $122.26 | 2021-2022 | |
| Janssen Scientific Affairs, LLC | $120.64 | 2019-2024 | Akeega, Balversa, Erleada |
| Bayer Healthcare Pharmaceuticals INC. | $101.56 | 2021-2024 | |
| Olympus America INC. | $88.88 | 2024 | Itind System |
| Innovation Technologies INC | $84.20 | 2022 | |
| Pfizer INC. | $59.33 | 2022-2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Photocure INC | $32.77 | 2022 | |
| Procept Biorobotics Corporation | $32.67 | 2024 | Aquabeam System |
| Dendreon Pharmaceuticals LLC | $32.31 | 2022 | |
| Merck Sharp & Dohme LLC | $30.74 | 2020-2025 | Keytruda Qlex, Keytruda |
| Neotract INC. | $30.07 | 2019 | |
| Urogen Pharma, INC. | $26.52 | 2025 | |
| Accord Healthcare, INC. | $24.70 | 2025 | |
| Endo USA, INC. | $21.95 | 2024 | Xiaflex |
| Verity Pharmaceuticals INC. | $19.71 | 2024 | Trelstar |
| Janssen Biotech, INC. | $17.13 | 2022 | |
| 180 Medical, INC. | $13.07 | 2024 | |
| Melinta Therapeutics, LLC | $12.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Soon-Sutton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.